Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries

The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear. A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and fo...

Full description

Saved in:
Bibliographic Details
Published inBMC cardiovascular disorders Vol. 24; no. 1; pp. 358 - 7
Main Authors Zhang, Xiao-jiao, Hou, Ai-jie, Luan, Bo, Wang, Cheng-fu, Li, Jia-jin
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 13.07.2024
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear. A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups. Patients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840-0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively. Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP.
AbstractList The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear.BACKGROUNDThe plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear.A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups.METHODSA total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups.Patients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840-0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively.RESULTSPatients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840-0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively.Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP.CONCLUSIONCombined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP.
Abstract Background The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear. Methods A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups. Results Patients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840–0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively. Conclusion Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP.
The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear. A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups. Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP.
BackgroundThe plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear.MethodsA total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups.ResultsPatients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840–0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively.ConclusionCombined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP.
Background The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear. Methods A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups. Results Patients with CSFP had a higher level of uric acid (392.3 [+ or -] 85.3 vs. 273.8 [+ or -] 71.5, P < 0.001), UAR (10.7 [+ or -] 2.2 vs. 7.2 [+ or -] 1.9, P < 0.001), but a lower level of plasma albumin (36.9 [+ or -] 4.2 vs. 38.5 [+ or -] 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840-0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively. Conclusion Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP. Keywords: Uric acid to albumin ratio, Coronary slow flow phenomenon, Chronic coronary syndrome, Predictors, Coronary artery disease
The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear. A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups. Patients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840-0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively. Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP.
ArticleNumber 358
Audience Academic
Author Zhang, Xiao-jiao
Wang, Cheng-fu
Luan, Bo
Hou, Ai-jie
Li, Jia-jin
Author_xml – sequence: 1
  givenname: Xiao-jiao
  surname: Zhang
  fullname: Zhang, Xiao-jiao
– sequence: 2
  givenname: Ai-jie
  surname: Hou
  fullname: Hou, Ai-jie
– sequence: 3
  givenname: Bo
  surname: Luan
  fullname: Luan, Bo
– sequence: 4
  givenname: Cheng-fu
  surname: Wang
  fullname: Wang, Cheng-fu
– sequence: 5
  givenname: Jia-jin
  surname: Li
  fullname: Li, Jia-jin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39003493$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu3CAUhq0qVXNpX6CLCqmbbpyCwTYso6iXSJG6adYIHyBDZMMUmER5nT5pz2SSThtVFeKq7_8PiP-4OYgpuqZ5y-gpY3L4WFgnx66lnWipwNb2L5ojJkbWdt3ADv5YHzbHpdxQykZJ1avmkCtKuVD8qPl5lQMQA8GSmoiZp80SIsmmBtwVYkhMt24m6-xsgJoy8dgh5RRNvidlTnfEb4f1ysW0YI8E9WvUu1gLuQt1RWCFOFbZy-6jzUgTEy0WiG2aSs0bqOHW7SmTq8vBldfNS2_m4t48zifN1edP38-_tpffvlycn1220FNZWzsBqGl00js_OA5UMmB0kkKAkEaOyo9UKuoGC3SYxDh55kB5Lqng_eQUP2kudr42mRu9zmHBW-hkgn44SPla45UCzE5z2xnLvLQcjGDWmpEpgKETvR2sUBS9Puy81jn92LhS9RIKuHk20aVN0ZyOSvWDoh2i75-hN2mTI74UKYVfrLhUe-raYP0QfarZwNZUn0nKumHgYkDq9B8UNuuWAJgeH_D8L8G7x-KbaXH296ufAoKA3AGQUynZeQ2hbtMR0TnMmlG9zaLeZVFjFvVDFnWP0u6Z9Mn9P6JfTbDisg
CitedBy_id crossref_primary_10_2147_IJGM_S481538
crossref_primary_10_1186_s12872_025_04507_z
crossref_primary_10_2147_IJGM_S516108
Cites_doi 10.1016/0735-1097(95)00088-L
10.1016/j.jjcc.2012.09.004
10.1177/00033197231161902
10.1177/00033197221110700
10.1159/000460239
10.1016/j.febslet.2008.04.057
10.1016/j.metabol.2017.06.006
10.1177/00033197221139685
10.1159/000336948
10.1002/hep.20720
10.1016/j.amjcard.2016.11.054
10.1016/j.numecd.2021.05.034
10.3390/jcm10204750
10.1532/hsf.2397
10.1016/j.ijcard.2017.04.003
10.5114/aoms.2015.51412
10.1016/j.cardfail.2011.02.010
10.1007/s11906-013-0344-5
10.1080/00365513.2022.2084698
10.1093/eurheartj/ehi879
10.1186/s12872-022-02798-0
10.1177/00033197211066362
10.3233/CH-2008-1079
10.1253/circj.CJ-12-0205
10.1038/s41392-022-00955-7
10.1056/NEJM199902113400607
10.1186/s12872-023-03579-z
10.3390/ijms24032960
10.1111/echo.14643
ContentType Journal Article
Copyright 2024. The Author(s).
COPYRIGHT 2024 BioMed Central Ltd.
2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024. The Author(s).
– notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOA
DOI 10.1186/s12872-024-04040-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


Publicly Available Content Database

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2261
EndPage 7
ExternalDocumentID oai_doaj_org_article_3d2ad1f8d3ca41dda719cc6245d6d490
A801266346
39003493
10_1186_s12872_024_04040_5
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ECGQY
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7QP
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-c508t-dbcc9b7e8fef6e3c081c10b844c48a879f70890e6dc06b47bf1ec9f380435be93
IEDL.DBID M48
ISSN 1471-2261
IngestDate Wed Aug 27 01:32:22 EDT 2025
Thu Jul 10 21:59:58 EDT 2025
Sat Jul 26 02:43:41 EDT 2025
Tue Jun 17 22:08:02 EDT 2025
Tue Jun 10 21:06:58 EDT 2025
Mon Jul 21 05:39:33 EDT 2025
Tue Jul 01 02:38:11 EDT 2025
Thu Apr 24 23:12:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Uric acid to albumin ratio
Coronary slow flow phenomenon
Chronic coronary syndrome
Coronary artery disease
Predictors
Language English
License 2024. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c508t-dbcc9b7e8fef6e3c081c10b844c48a879f70890e6dc06b47bf1ec9f380435be93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/3091289389?pq-origsite=%requestingapplication%
PMID 39003493
PQID 3091289389
PQPubID 44077
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_3d2ad1f8d3ca41dda719cc6245d6d490
proquest_miscellaneous_3079956902
proquest_journals_3091289389
gale_infotracmisc_A801266346
gale_infotracacademiconefile_A801266346
pubmed_primary_39003493
crossref_citationtrail_10_1186_s12872_024_04040_5
crossref_primary_10_1186_s12872_024_04040_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-07-13
PublicationDateYYYYMMDD 2024-07-13
PublicationDate_xml – month: 07
  year: 2024
  text: 2024-07-13
  day: 13
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC cardiovascular disorders
PublicationTitleAlternate BMC Cardiovasc Disord
PublicationYear 2024
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References G Genc Tapar (4040_CR5) 2020; 37
MC Leone (4040_CR18) 2008; 39
GJ Quinlan (4040_CR13) 2005; 41
C Gabay (4040_CR27) 1999; 340
M Roche (4040_CR14) 2008; 582
JF Beltrame (4040_CR1) 2012; 76
SG Nurkoç (4040_CR31) 2024; 75
H González-Pacheco (4040_CR24) 2017; 119
A Maloberti (4040_CR10) 2021; 10
Y Wang (4040_CR6) 2017; 138
SC Chien (4040_CR25) 2017; 241
Z Soltani (4040_CR11) 2013; 15
S Li (4040_CR17) 2022; 82
T Çınar (4040_CR30) 2023; 74
XT Dai (4040_CR3) 2022; 22
AR Aroor (4040_CR8) 2017; 74
M Selçuk (4040_CR29) 2022; 74
IM Caglar (4040_CR23) 2016; 12
S Kalkan (4040_CR15) 2022; 73
GM Lin (4040_CR21) 2013; 61
P Kong (4040_CR12) 2022; 7
S Arques (4040_CR26) 2011; 17
D Yalcinkaya (4040_CR28) 2024; 75
C Ruggiero (4040_CR9) 2006; 27
EÖ Çakmak (4040_CR16) 2021; 8
E Russo (4040_CR7) 2023; 24
Y Xing (4040_CR20) 2019; 22
SB Yang (4040_CR2) 2023; 23
V Kopetz (4040_CR4) 2012; 121
GS Mintz (4040_CR19) 1995; 25
X Wang (4040_CR22) 2021; 31
References_xml – volume: 8
  start-page: 99
  issue: 3–4
  year: 2021
  ident: 4040_CR16
  publication-title: Pulse (Basel)
– volume: 25
  start-page: 1479
  issue: 7
  year: 1995
  ident: 4040_CR19
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(95)00088-L
– volume: 61
  start-page: 122
  issue: 2
  year: 2013
  ident: 4040_CR21
  publication-title: J Cardiol
  doi: 10.1016/j.jjcc.2012.09.004
– volume: 75
  start-page: 386
  issue: 4
  year: 2024
  ident: 4040_CR28
  publication-title: Angiology
  doi: 10.1177/00033197231161902
– volume: 74
  start-page: 381
  issue: 4
  year: 2023
  ident: 4040_CR30
  publication-title: Angiology
  doi: 10.1177/00033197221110700
– volume: 74
  start-page: 156
  issue: 3
  year: 2022
  ident: 4040_CR29
  publication-title: Rev Invest Clin
– volume: 138
  start-page: 141
  issue: 3
  year: 2017
  ident: 4040_CR6
  publication-title: Cardiology
  doi: 10.1159/000460239
– volume: 582
  start-page: 1783
  issue: 13
  year: 2008
  ident: 4040_CR14
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2008.04.057
– volume: 74
  start-page: 32
  year: 2017
  ident: 4040_CR8
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2017.06.006
– volume: 75
  start-page: 72
  issue: 1
  year: 2024
  ident: 4040_CR31
  publication-title: Angiology
  doi: 10.1177/00033197221139685
– volume: 121
  start-page: 197
  issue: 3
  year: 2012
  ident: 4040_CR4
  publication-title: Cardiology
  doi: 10.1159/000336948
– volume: 41
  start-page: 1211
  issue: 6
  year: 2005
  ident: 4040_CR13
  publication-title: Hepatology
  doi: 10.1002/hep.20720
– volume: 119
  start-page: 951
  issue: 7
  year: 2017
  ident: 4040_CR24
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2016.11.054
– volume: 31
  start-page: 2756
  issue: 10
  year: 2021
  ident: 4040_CR22
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2021.05.034
– volume: 10
  start-page: 4750
  issue: 20
  year: 2021
  ident: 4040_CR10
  publication-title: J Clin Med
  doi: 10.3390/jcm10204750
– volume: 22
  start-page: E247
  issue: 3
  year: 2019
  ident: 4040_CR20
  publication-title: Heart Surg Forum
  doi: 10.1532/hsf.2397
– volume: 241
  start-page: 1
  year: 2017
  ident: 4040_CR25
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2017.04.003
– volume: 12
  start-page: 31
  issue: 1
  year: 2016
  ident: 4040_CR23
  publication-title: Arch Med Sci
  doi: 10.5114/aoms.2015.51412
– volume: 17
  start-page: 451
  issue: 6
  year: 2011
  ident: 4040_CR26
  publication-title: J Card Fail
  doi: 10.1016/j.cardfail.2011.02.010
– volume: 15
  start-page: 175
  issue: 3
  year: 2013
  ident: 4040_CR11
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-013-0344-5
– volume: 82
  start-page: 304
  issue: 4
  year: 2022
  ident: 4040_CR17
  publication-title: Scand J Clin Lab Invest
  doi: 10.1080/00365513.2022.2084698
– volume: 27
  start-page: 1174
  issue: 10
  year: 2006
  ident: 4040_CR9
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehi879
– volume: 22
  start-page: 362
  issue: 1
  year: 2022
  ident: 4040_CR3
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/s12872-022-02798-0
– volume: 73
  start-page: 461
  issue: 5
  year: 2022
  ident: 4040_CR15
  publication-title: Angiology
  doi: 10.1177/00033197211066362
– volume: 39
  start-page: 185
  issue: 1–4
  year: 2008
  ident: 4040_CR18
  publication-title: Clin Hemorheol Microcirc
  doi: 10.3233/CH-2008-1079
– volume: 76
  start-page: 818
  issue: 4
  year: 2012
  ident: 4040_CR1
  publication-title: Circulation Journal: Official J Japanese Circulation Soc
  doi: 10.1253/circj.CJ-12-0205
– volume: 7
  start-page: 131
  issue: 1
  year: 2022
  ident: 4040_CR12
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-022-00955-7
– volume: 340
  start-page: 448
  issue: 6
  year: 1999
  ident: 4040_CR27
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199902113400607
– volume: 23
  start-page: 540
  issue: 1
  year: 2023
  ident: 4040_CR2
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/s12872-023-03579-z
– volume: 24
  start-page: 2960
  issue: 3
  year: 2023
  ident: 4040_CR7
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms24032960
– volume: 37
  start-page: 528
  issue: 4
  year: 2020
  ident: 4040_CR5
  publication-title: Echocardiography
  doi: 10.1111/echo.14643
SSID ssj0017809
Score 2.392311
Snippet The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow...
Background The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary...
BackgroundThe plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary...
Abstract Background The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and...
SourceID doaj
proquest
gale
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
StartPage 358
SubjectTerms Aged
Albumin
Angina pectoris
Angiography
Atherosclerosis
Biomarkers - blood
Blood
Blood flow
Cardiovascular disease
Case-Control Studies
Cholesterol
Chronic coronary syndrome
Chronic Disease
Complications and side effects
Contrast agents
Coronary Angiography
Coronary artery
Coronary artery disease
Coronary Artery Disease - blood
Coronary Artery Disease - diagnosis
Coronary Artery Disease - diagnostic imaging
Coronary Artery Disease - physiopathology
Coronary Circulation
Coronary heart disease
Coronary slow flow phenomenon
Coronary vessels
Coronary Vessels - diagnostic imaging
Coronary Vessels - physiopathology
Diagnosis
Female
Health aspects
Heart attacks
Humans
Hypertension
Laboratories
Logistics
Male
Measurement
Medical examination
Medical imaging
Middle Aged
No-Reflow Phenomenon - blood
No-Reflow Phenomenon - diagnosis
No-Reflow Phenomenon - diagnostic imaging
No-Reflow Phenomenon - etiology
No-Reflow Phenomenon - physiopathology
Pathophysiology
Plasma
Predictive Value of Tests
Predictors
Regression analysis
Retrospective Studies
Risk Factors
Serum Albumin, Human - analysis
Stenosis
Trinucleotide repeats
Uric acid
Uric Acid - blood
Uric acid to albumin ratio
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yB_EifltdJYLgQcKmTZqP4youi7CefLC3kK_CwqNdtm9X_Hf8S51J8577FPTipYd2pk06k8xvmukvhLxNRtvBJM6Sh4MUIrDQ4hcxI4egjfBdqao8-6JOV_LzeX9-a6svrAlb6IGXF3ckUudTC7cT0cs2Ja9bG6PqZJ9UkrZk6xDztslUXT_QhtvtLzJGHc0wC-uOQTxi4LSSs34vDBW2_j_n5N-QZok4Jw_I_QoV6fHSxIfkTh4fkbtndTH8MfmxgjmM-niR6Gaipc74YqTFotTP1NNxuslrenmFGpBaU8CnNCJjgb_6Tuf19I0OeMAqL-RhmEYK-pVodab4hZbGhTv3llplOKB-TPCAkU2hUtDe5F9SpVAUcvAnZHXy6evHU1a3XGARkNqGpRCjDTqbIQ8qiwiAIbY8GCmjNB7tqrmxPKsUuQpSh6HN0Q7CcIBdIVvxlBzAs_NzQtvcgcEtbjwBkKszuILb--CVtn3QMjek3VrAxcpHjttirF3JS4xyi9UcWM0Vq7m-Ie93OpcLG8dfpT-gYXeSyKRdToB_uepf7l_-1ZB36BYOxzs0L_r62wJ0Epmz3DGGeIBtUjXkcE8Sxmncv7x1LFfnidkJcF1IeQE1NuTN7jJqYu3bmKdrlEHSPmV515Bni0PuuiRsIRgSL_5HV1-Se10ZIpq14pAcgPfkVwC5NuF1GV0_AaTPKPg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgifls9JYLgg4RrmzQfT3KKxyGcTy7sW8hX5WBp97bryf0795c6k83uuQr30od2Jm2ZyXwkk98Q8j5qZXodaxYdXATnnvkGV8S06L3S3LW5qvLsuzydiW_zbl4W3KZSVrm1idlQxzHgGvkRB8cGyQH410_LC4Zdo3B3tbTQuEvuIXQZarWa7xKuRunabA_KaHk0wQCqZeCVGKiuqFm354wyZv__lvmfeDP7nZNH5GEJGOnxRsKPyZ00PCH3z8qW-FNyPQNLRl04j3Q90lxtfD7QLFfqJuroMF6mBV2ukAMSbApRKg2IW-BWV3RajL9pjxes9UI0hnGgwF_gVieK67Q0bBB0_2IrOAfUDRFeMLDRFyDay3RDlctFIRN_RmYnX398OWWl8QILEK-tWfQhGK-S7lMvEw8QNoSm9lqIILRD6apamzrJGGrphfJ9k4Lpua4h-PLJ8OfkAN6dXhLapBbEbrD9BARercZ93M55J5XpvBKpIs1WAjYUVHJsjrGwOTvR0m6kZkFqNkvNdhX5uONZbjA5bqX-jILdUSKedr4xrn7aMj0tj62LDSgtD040MTrVmBBkK7ooozB1RT6gWlic9fB5wZXDC_CTiJ9lj9HRQ_AmZEUO9yhhtob9x1vFssVaTPZGtyvybvcYObECbkjjL6RB6D5p6rYiLzYKufslbjLMEH91--CvyYM2K79iDT8kB6AX6Q2EVGv_Ns-bP1DUH8o
  priority: 102
  providerName: ProQuest
Title Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries
URI https://www.ncbi.nlm.nih.gov/pubmed/39003493
https://www.proquest.com/docview/3091289389
https://www.proquest.com/docview/3079956902
https://doaj.org/article/3d2ad1f8d3ca41dda719cc6245d6d490
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBf9gLGXse-564IGgz0Mb5YlW9LDGM1oKYOUURYIexH6cikEu0uydv139pfuTnHSZSt90YN9Z8W5O-kn6fw7Qt4EJXWjQpEHC43g3OWO4Y6YEo2TitsyZVWOTurjsfgyqSZbZFXuqP8D57cu7bCe1Hg2ff_rx_UnCPiPKeBV_WEOY6wsc5htcnBJUeTVNtmFmUliRYORuDlVkCqlfDAYkHOAHWz1Ec2tz9iYqBKf__-j9j9YNM1JRw_Jgx5M0oOl9R-Rrdg-JvdG_XH5E_J7DKMctf480EVHUybyeUuTzamdU0vb7jJO6cUMNWDxTQHBUo-cBnZ2TefT7oo22GAeGDI1dC0F_Z6KdU5xD5f6JbvuX2o9BwK1bYAO2rxzPUntZbyRSqmksEp_SsZHh98-H-d9UYbcA5Zb5MF5r52MqolNHbkHSOFZ4ZQQXiiLlpeF0kWsgy9qJ6RrWPS64aoAYOai5s_IDvQdXxDKYgkuobE0BYCyUuEZb2WdraWunBQxI2xlAeN7xnIsnDE1aeWiarO0mgGrmWQ1U2Xk3VrnYsnXcaf0EA27lkSu7XShm52ZPnQND6UNDByaeytYCFYy7X1diirUQegiI2_RLQz6KPw8b_sPG-AlkVvLHCAIAGAn6ozsb0hCJPvN2yvHMqtAMBwAHSyKAVdm5PX6Nmpidlwbu58og7R-tS7KjDxfOuT6lbhOFER87-6-X5L7ZXJ-mTO-T3bAL-IrgFsLNyDbciIHZHd4ePL1dJA2LQYprqA9HX7_A7_gKOU
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgEXxJtAASOBOKCoTuLEzgGh8qi2tNtTV9qb8Suo0ipZNkur_h1-AL-RGedRFqTeeskhGSeO5m2PvyHktZOirKRjsdNw4VlmYpPgipjklREy02moqpweF5MZ_zrP51vk93AWBssqB5sYDLVrLK6R72bg2CA5AP_6Yfkjxq5RuLs6tNDoxOLQX5xDyta-P_gM_H2TpvtfTj5N4r6rQGwhGFnHzlhbGuFl5avCZxZ8ok2YkZxbLjVOXTBZMl84ywrDhakSb8sqkwwiC-MRfAlM_g1wvAyTPTEfE7xESFYOB3NksdvChEUagxeMQVU4i_MN5xd6BPzvCf6Jb4Of279L7vQBKt3rJOoe2fL1fXJz2m_BPyC_ZmA5qbanjq4bGqqbT2sa5IjqlmpaN2d-QZcrHAEJPYWomFrESdCrC9oumnNa4QVryxD9oakpjO_hXVuK68LUdoi9fw3rcRWorh18oI4b0wPfnvlLqlCeCpn_QzK7FpY8Itvwbf-E0MSnIGYltruAQC-VuG-ca6MLUeZGcB-RZOCAsj0KOjbjWKiQDclCdVxTwDUVuKbyiLwbxyw7DJArqT8iY0dKxO8ON5rVd9WbA5W5VLsElCSzmifOaZGU1hYpz13heMki8hbFQqGVgelZ3R-WgJ9EvC61h4EFBIu8iMjOBiVYB7v5eBAs1VunVl3qUkRejY9xJFbc1b75iTQIFViULI3I404gx1_KygBrlD29-uUvya3JyfRIHR0cHz4jt9OgCCJOsh2yDTLin0M4tzYvgg5R8u26lfYPNK5dvQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Uric+acid+to+albumin+ratio+as+a+novel+predictor+for+coronary+slow+flow+phenomenon+in+patients+with+chronic+coronary+syndrome+and+non-obstructive+coronary+arteries&rft.jtitle=BMC+cardiovascular+disorders&rft.au=Zhang%2C+Xiao-jiao&rft.au=Hou%2C+Ai-jie&rft.au=Luan%2C+Bo&rft.au=Wang%2C+Cheng-fu&rft.date=2024-07-13&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2261&rft.eissn=1471-2261&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs12872-024-04040-5&rft.externalDocID=A801266346
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2261&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2261&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2261&client=summon